Clinical Implications of Mutations of Neutrophil Elastase in Congenital and Cyclic Neutropenia
- 1 May 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 23 (4) , 208-210
- https://doi.org/10.1097/00043426-200105000-00005
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropeniaBlood, 2000
- Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesisNature Genetics, 1999
- Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule developmentEuropean Journal of Haematology, 1997
- Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesisAmerican Journal of Medical Genetics, 1996
- Dominantly inherited severe congenital neutropeniaJournal of Infection, 1996
- A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropeniaBlood, 1993
- Effects of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutropenia in Patients with Congenital AgranulocytosisNew England Journal of Medicine, 1989
- Treatment of Cyclic Neutropenia with Granulocyte Colony-Stimulating FactorNew England Journal of Medicine, 1989
- Periodic Hematopoiesis in Human Cyclic NeutropeniaJournal of Clinical Investigation, 1973
- Infantile Genetic Agranulocytosis (Agranulocytosis infantilis hereditaria) A New Recessive Lethal Disease in ManActa Paediatrica, 1956